Fierce Pharma2d
Manufacturing issues trip up Milestone's long-awaited FDA landmark
Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a ...
Knowridge Science Report15h
Could a common blood pressure medicine raise risk of vision loss?
A new study from the UK suggests that a widely used blood pressure medicine—Calcium Channel Blockers (CCBs)—may be linked to ...
Knowridge Science Report15h
Can blood pressure medicine affect your bowel health?
The researchers believe that this type of calcium channel blocker may affect the muscles in the intestines, making it harder ...
MPR2d
FDA Decision on Etripamil Nasal Spray Delayed Due to Nonclinical Issues
The Food and Drug Administration (FDA) has issued a Complete Response Letter to Milestone Pharmaceuticals regarding the New Drug Application (NDA) for ...
PharmiWeb10d
At a CAGR of 5.7%, Calcium Channel Blockers Market: Rising Demand for Cardiovascular Solutions & Drug Innovation Through 2035 - TMR Research
The Calcium Channel Blockers Market was valued at US$ 14.5 Bn in 2022 and is projected to grow at a CAGR of 5.7% from 2023 to ...
MedPage Today6d
Different Post-CABG Meds May Help Radial Artery Graft Patency
In current European and American revascularization guidelines, RA grafts are now strongly endorsed as the second conduit for CABG based on easy harvesting and relative greater patency over time, among ...